InMode Ltd. (INMD)

Market Cap	1.46B
Revenue (ttm)	492.05M
Net Income (ttm)	197.92M
Shares Out	84.62M
EPS (ttm)	2.30
PE Ratio	7.49
Forward PE	6.98
Dividend	n/a
Ex-Dividend Date	n/a

Volume	912,355
Open	17.20
Previous Close	17.14
Day's Range	17.07 - 17.49
52-Week Range	16.82 - 48.25
Beta	2.16
Analysts	Hold
Price Target	32.80 (+90.37%)
Earnings Date	May 2, 2024

About INMD

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also des...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2019
• Employees: 581
• Stock Exchange: NASDAQ
• Ticker Symbol: INMD

Financial Performance

In 2023, InMode's revenue was $492.05 million, an increase of 8.32% compared to the previous year's $454.27 million. Earnings were $197.92 million, an increase of 22.54%.

Analyst Forecast

According to 6 analysts, the average rating for INMD stock is "Hold." The 12-month stock price forecast is $32.8, which is an increase of 90.37% from the latest price.

Price Target

$32.8

(90.37% upside)

Analyst Consensus: Hold